MG
IVA

Michael Gelband’s Inventiva IVA Stock Holding History

Michael Gelband’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,256
Closed -$212K – 1811
2026
Q1 		$212K Buy
+38,256
New +$233K ﹤0.01% 1368

Other funds holding IVA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Michael Gelband's IVA Position: Q2 2026 in Review

Michael Gelband sold out of Inventiva (IVA) in Q2 2026, closing a stake of 38,256 shares — an estimated $212K sold.

Michael Gelband first reported a position in IVA in Q1 2026 and held it in 1 quarter. The position peaked at $212K in Q1 2026. 88 funds tracked by Wall St. Rank hold IVA as of Q2 2026.

  • Michael Gelband reported no remaining Inventiva position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 38,256 Inventiva shares in Q2 2026, an estimated $212K.
  • Michael Gelband first reported a position in Inventiva in Q1 2026 and held it in 1 quarter.
  • Michael Gelband's Inventiva position peaked at $212K in Q1 2026.
  • 88 funds tracked by Wall St. Rank held Inventiva as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.